Logo - springer
Slogan - springer

Biomedical Sciences - Neuroscience | Psychopharmacology - incl. option to publish open access

Psychopharmacology

Psychopharmacology

Coordinating Editor: T.W. Robbins; K.A. Miczek; C. Baunez
Principal Editors: O. Howes; D. Hoyer; H. de Wit; V.H. Curran; L.H. Price; I. Lucki; A.L. Morrow

ISSN: 0033-3158 (print version)
ISSN: 1432-2072 (electronic version)

Journal no. 213

$199.00 Personal Rate e-only for the Americas
Get Subscription

Online subscription, valid from January through December of current calendar year

Immediate access to this year's issues via SpringerLink

1 Volume(-s) with 24 issue(-s) per annual subscription

Automatic annual renewal

More information: >> FAQs // >> Policy

Learn more about the metrics of this journal European Behavioural Pharmacological Society
  • Publishes research and reviews of mechanisms by which drugs affect behavior
  • Extends from clinical psychopharmacology to studies of effects of drugs on human cognition and behavior
  • Covers methodologies from neurochemical assays to functional neuroimaging studies

Official Journal of the European Behavioural Pharmacology Society (EBPS)

Psychopharmacology is an international journal that covers the broad topic of elucidating mechanisms by which drugs affect behavior. The scope of the journal encompasses the following fields:

Human Psychopharmacology: Experimental

This section includes manuscripts describing the effects of drugs on mood, behavior, cognition and physiology in humans.  The journal encourages submissions that involve brain imaging, genetics, neuroendocrinology, and developmental topics.  Usually manuscripts in this section describe studies conducted under controlled conditions, but occasionally descriptive or observational studies are also considered.

Human Psychopharmacology: Clinical and Translational

This section comprises studies addressing the broad intersection of drugs and psychiatric illness. This includes not only clinical trials and studies of drug usage and metabolism, drug surveillance, and pharmacoepidemiology, but also work utilizing the entire range of clinically relevant methodologies, including neuroimaging, pharmacogenetics, cognitive science, biomarkers, and others. Work directed toward the translation of preclinical to clinical knowledge is especially encouraged. The key feature of submissions to this section is that they involve a focus on clinical aspects.

Preclinical psychopharmacology: Behavioral and Neural

This section considers reports on the effects of compounds with defined chemical structures on any aspect of behavior, in particular when correlated with neurochemical effects, in species other than humans. Manuscripts containing neuroscientific techniques in combination with behavior are welcome. We encourage reports of studies that provide insight into the mechanisms of drug action, at the behavioral and molecular levels.

Preclinical Psychopharmacology: Translational

This section considers manuscripts that enhance the confidence in a central mechanism that could be of therapeutic value for psychiatric or neurological patients, using disease-relevant preclinical models and tests, or that report on preclinical manipulations and challenges that have the potential to be translated to the clinic. Studies aiming at the refinement of preclinical models based upon clinical findings (back-translation) will also be considered. The journal particularly encourages submissions that integrate measures of target tissue exposure, activity on the molecular target and/or modulation of the targeted biochemical pathways.

Preclinical Psychopharmacology: Molecular, Genetic and Epigenetic

This section focuses on the molecular and cellular actions of neuropharmacological agents / drugs, and the identification / validation of drug targets affecting the CNS in health and disease. We particularly encourage studies that provide insight into the mechanisms of drug action at the molecular level. Manuscripts containing evidence for genetic or epigenetic effects on neurochemistry or behavior are welcome. 

The journal welcomes submissions in all of these fields.

Related subjects » Neuroscience - Pharmacology & Toxicology - Psychiatry

Impact Factor: 3.308 (2016) * 

Journal Citation Reports®

Abstracted/Indexed in 

Science Citation Index, Science Citation Index Expanded (SciSearch), Journal Citation Reports/Science Edition, Medline, SCOPUS, PsycINFO, EMBASE, Chemical Abstracts Service (CAS), Google Scholar, CAB International, Academic OneFile, Biological Abstracts, BIOSIS, CAB Abstracts, ChemWeb, Current Abstracts, Current Contents/ Life Sciences, EBSCO Academic Search, EBSCO Advanced Placement Source, EBSCO Biomedical Reference Collection, EBSCO CINAHL, EBSCO Pharmacy Collection: India, EBSCO Psychology & Behavioral Sciences Collection, EBSCO Rehabilitation & Sports Medicine Source, EBSCO SPORTDiscus, EBSCO STM Source, EBSCO TOC Premier, ERIH PLUS, Food Science and Technology Abstracts, Gale, Global Health, Health Reference Center Academic, Highbeam, International Bibliography of Book Reviews (IBR), International Bibliography of Periodical Literature (IBZ), OCLC, PSYCLINE, Reaxys, SCImago, Studies on Women & Gender Abstracts, Summon by ProQuest

For authors and editors


  • Journal Citation Reports®
    2016 Impact Factor
  • 3.308
  • Aims and Scope

    Aims and Scope

    Close

    Psychopharmacology is an international journal of research and scholarship, the aims of which are to cover the general area of elucidating the neurochemical mechanisms that affect behavior, all terms understood in the broadest sense. The scope of the Journal extends from clinical psychopharmacology (including trials), to experimental studies on the effects of drugs on cognition and behavior in humans and laboratory studies in experimental animals. The research methodologies (techniques covered) may range from neurochemical assays and electrophysiological recording to studies of functional neuroimaging, and the methods of experimental psychology and ethology, as well as clinical neurology and psychiatry. The journal is particularly interested in articles that integrate these levels of analysis.

  • Submit Online
  • Open Choice - Your Way to Open Access
  • Author Information

    Author Information

    Close

  • Author Academy: Training for Authors
  • Copyright Information

    Copyright Information

    Close

    Copyright Information

    For Authors

    Submission of a manuscript implies: that the work described has not been published before (except in form of an abstract or as part of a published lecture, review or thesis); that it is not under consideration for publication elsewhere; that its publication has been approved by all co-authors, if any, as well as – tacitly or explicitly – by the responsible authorities at the institution where the work was carried out.

    Author warrants (i) that he/she is the sole owner or has been authorized by any additional copyright owner to assign the right, (ii) that the article does not infringe any third party rights and no license from or payments to a third party is required to publish the article and (iii) that the article has not been previously published or licensed. The author signs for and accepts responsibility for releasing this material on behalf of any and all co-authors. Transfer of copyright to Springer (respective to owner if other than Springer) becomes effective if and when a Copyright Transfer Statement is signed or transferred electronically by the corresponding author. After submission of the Copyright Transfer Statement signed by the corresponding author, changes of authorship or in the order of the authors listed will not be accepted by Springer.

    The copyright to this article, including any graphic elements therein (e.g. illustrations, charts, moving images), is assigned for good and valuable consideration to Springer effective if and when the article is accepted for publication and to the extent assignable if assignability is restricted for by applicable law or regulations (e.g. for U.S. government or crown employees).

    The copyright assignment includes without limitation the exclusive, assignable and sublicensable right, unlimited in time and territory, to reproduce, publish, distribute, transmit, make available and store the article, including abstracts thereof, in all forms of media of expression now known or developed in the future, including pre- and reprints, translations, photographic reproductions and microform. Springer may use the article in whole or in part in electronic form, such as use in databases or data networks for display, print or download to stationary or portable devices. This includes interactive and multimedia use and the right to alter the article to the extent necessary for such use.

    Authors may self-archive the Author's accepted manuscript of their articles on their own websites. Authors may also deposit this version of the article in any repository, provided it is only made publicly available 12 months after official publication or later. He/she may not use the publisher's version (the final article), which is posted on SpringerLink and other Springer websites, for the purpose of self-archiving or deposit. Furthermore, the Author may only post his/her version provided acknowledgement is given to the original source of publication and a link is inserted to the published article on Springer's website. The link must be accompanied by the following text: "The final publication is available at link.springer.com".

    Prior versions of the article published on non-commercial pre-print servers like arXiv.org can remain on these servers and/or can be updated with Author's accepted version. The final published version (in pdf or html/xml format) cannot be used for this purpose. Acknowledgement needs to be given to the final publication and a link must be inserted to the published article on Springer's website, accompanied by the text "The final publication is available at link.springer.com". Author retains the right to use his/her article for his/her further scientific career by including the final published journal article in other publications such as dissertations and postdoctoral qualifications provided acknowledgement is given to the original source of publication.

    Author is requested to use the appropriate DOI for the article. Articles disseminated via link.springer.com are indexed, abstracted and referenced by many abstracting and information services, bibliographic networks, subscription agencies, library networks, and consortia.

    For Readers

    While the advice and information in this journal is believed to be true and accurate at the date of its publication, neither the authors, the editors, nor the publisher can accept any legal responsibility for any errors or omissions that may have been made. The publisher makes no warranty, express or implied, with respect to the material contained herein.

    All articles published in this journal are protected by copyright, which covers the exclusive rights to reproduce and distribute the article (e.g., as offprints), as well as all translation rights. No material published in this journal may be reproduced photographically or stored on microfilm, in electronic data bases, video disks, etc., without first obtaining written permission from the publisher (respective the copyright owner if other than Springer). The use of general descriptive names, trade names, trademarks, etc., in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.

    Springer has partnered with Copyright Clearance Center's RightsLink service to offer a variety of options for reusing Springer content. For permission to reuse our content please locate the material that you wish to use on link.springer.com or on springerimages.com and click on the permissions link or go to copyright.com, then enter the title of the publication that you wish to use. For assistance in placing a permission request, Copyright Clearance Center can be connected directly via phone: +1-855-239-3415, fax: +1-978-646-8600, or e-mail: info@copyright.com.


    © Springer-Verlag Berlin Heidelberg

Services for the Journal

Alerts for this journal

 

Get the table of contents of every new issue published in Psychopharmacology.


Additional information